Norges Bank’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,373,360
| Closed | -$3.76M | – | 2202 |
|
|
2017
Q4 | $3.76M | Buy |
1,373,360
+104,701
| +8% | +$287K | ﹤0.01% | 1907 |
|
|
2017
Q3 | $4.3M | Sell |
1,268,659
-358,416
| -22% | -$1.22M | ﹤0.01% | 1887 |
|
|
2017
Q2 | $4.02M | Sell |
1,627,075
-315,000
| -16% | -$778K | ﹤0.01% | 1919 |
|
|
2017
Q1 | $4.41M | Sell |
1,942,075
-448,430
| -19% | -$1.02M | ﹤0.01% | 1906 |
|
|
2016
Q4 | $5.07M | Buy |
2,390,505
+264,517
| +12% | +$561K | ﹤0.01% | 1859 |
|
|
2016
Q3 | $6.8M | Buy |
2,125,988
+302,500
| +17% | +$968K | ﹤0.01% | 1802 |
|
|
2016
Q2 | $5.73M | Buy |
1,823,488
+735,442
| +68% | +$2.31M | ﹤0.01% | 1839 |
|
|
2016
Q1 | $3.62M | Buy |
1,088,046
+137,000
| +14% | +$456K | ﹤0.01% | 1915 |
|
|
2015
Q4 | $3.37M | Sell |
951,046
-494,074
| -34% | -$1.75M | ﹤0.01% | 1949 |
|
|
2015
Q3 | $7.27M | Buy |
1,445,120
+149,403
| +12% | +$752K | ﹤0.01% | 1728 |
|
|
2015
Q2 | $8.33M | Hold |
1,295,717
| – | – | ﹤0.01% | 1723 |
|
|
2015
Q1 | $9.12M | Sell |
1,295,717
-115,413
| -8% | -$812K | ﹤0.01% | 1685 |
|
|
2014
Q4 | $10.9M | Sell |
1,411,130
-303,264
| -18% | -$2.34M | 0.01% | 1597 |
|
|
2014
Q3 | $12.8M | Sell |
1,714,394
-1,714,394
| -50% | -$12.8M | 0.01% | 1432 |
|
|
2014
Q2 | $33.2M | Buy |
3,428,788
+2,359,352
| +221% | +$22.8M | 0.01% | 1282 |
|
|
2014
Q1 | $8.89M | Hold |
1,069,436
| – | – | 0.01% | 1639 |
|
|
2013
Q4 | $9.03M | Hold |
1,069,436
| – | – | 0.01% | 1630 |
|
|
2013
Q3 | $8.52M | Buy |
1,069,436
+375,736
| +54% | +$2.99M | 0.01% | 1648 |
|
|
2013
Q2 | $5.36M | Buy |
+693,700
| New | +$5.36M | ﹤0.01% | 1810 |
|